- Home
- IBIO vs DCGO Comparison
IBIO vs DCGO Comparison
Compare IBIO & DCGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IBIO | DCGO |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Managed Health Care |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.2M | 71.0M |
| IPO Year | 2009 | 2020 |
Fundamental Metrics
Financial Performance| Metric | IBIO | DCGO |
|---|---|---|
| Price | $1.88 | $0.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $4.75 | $2.38 |
| AVG Volume (30 Days) | ★ 672.8K | 587.9K |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 73.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $322,196,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.77 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.56 | $0.49 |
| 52 Week High | $3.82 | $1.78 |
Technical Indicators
Market Signals| Indicator | IBIO | DCGO |
|---|---|---|
| Relative Strength Index (RSI) | 51.76 | 38.57 |
| Support Level | $1.70 | $0.51 |
| Resistance Level | $2.00 | $0.67 |
| Average True Range (ATR) | 0.17 | 0.05 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 64.25 | 18.11 |
Price Performance
Historical ComparisonAbout IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
About DCGO DocGo Inc.
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has two reporting segments: Mobile Health Services and Transportation Services. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.